Blockade of the mineralocorticoid receptor improves markers of human endothelial cell dysfunction and hematological indices in a mouse model of sickle cell disease

Author:

Rivera Alicia12ORCID,Vega Christopher3,Ramos‐Rivera Arelys3,Maldonado Enrique R.3,Prado Gregory N.23,Karnes Hope E.4,Fesko Yuri A.4,Snyder L. Michael4,Alper Seth L.1ORCID,Romero Jose R.3ORCID

Affiliation:

1. Division of Nephrology, Vascular Biology Research Center, Department of Medicine, Beth Israel Deaconess Medical Center Harvard Medical School Boston Massachusetts USA

2. Departments of Laboratory Medicine and Pathology Boston Children's Hospital, Harvard Medical School Boston Massachusetts USA

3. Division of Endocrinology, Diabetes and Hypertension, Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston Massachusetts USA

4. Quest Diagnostics Secaucus New Jersey USA

Abstract

AbstractIncreased endothelin‐1 (ET‐1) levels in patients with sickle cell disease (SCD) and transgenic mouse models of SCD contribute to disordered hematological, vascular, and inflammatory responses. Mineralocorticoid receptor (MR) activation by aldosterone, a critical component of the Renin‐Angiotensin‐Aldosterone‐System, modulates inflammation and vascular reactivity, partly through increased ET‐1 expression. However, the role of MR in SCD remains unclear. We hypothesized that MR blockade in transgenic SCD mice would reduce ET‐1 levels, improve hematological parameters, and reduce inflammation. Berkeley SCD (BERK) mice, a model of severe SCD, were randomized to either sickle standard chow or chow containing the MR antagonist (MRA), eplerenone (156 mg/Kg), for 14 days. We found that MRA treatment reduced ET‐1 plasma levels (p = .04), improved red cell density gradient profile (D50; p < .002), and increased mean corpuscular volume in both erythrocytes (p < .02) and reticulocytes (p < .024). MRA treatment also reduced the activity of the erythroid intermediate‐conductance Ca2+‐activated K+ channel – KCa3.1 (Gardos channel, KCNN4), reduced cardiac levels of mRNAs encoding ET‐1, Tumor Necrosis Factor Receptor‐1, and protein disulfide isomerase (PDI) (p < .01), and decreased plasma PDI and myeloperoxidase activity. Aldosterone (10−8 M for 24 h in vitro) also increased PDI mRNA levels (p < .01) and activity (p < .003) in EA.hy926 human endothelial cells, in a manner blocked by pre‐incubation with the MRA canrenoic acid (1 μM; p < .001). Our results suggest a novel role for MR activation in SCD that may exacerbate SCD pathophysiology and clinical complications.

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3